Core Viewpoint - The National Computer Virus Emergency Response Center has identified 70 mobile applications that illegally collect and use personal information, highlighting ongoing concerns regarding data privacy and compliance with Chinese laws [1] Company Summary - The application "Ark Health Online Pharmacy" (version 6.42.0, OPPO software store) has been flagged for multiple violations, including failure to inform users about the transfer of their personal information to other parties and not providing a convenient way to withdraw consent for data collection [1] - Ark Health Online Pharmacy is operated by Guangzhou Ark Pharmaceutical Co., Ltd., which is a wholly-owned subsidiary of Guangzhou Ark Cloud Health Information Technology Group Co., Ltd. [1] - Established in 2015, Ark Health focuses on internet-based chronic disease management services and aims to become the largest chronic disease service platform in China [1]

Key Points - The top three stocks with net inflows from southbound funds are China Life (02628) with 1.58 billion, Southern Hang Seng Technology (03033) with 768 million, and Alibaba-W (09988) with 452 million [1][2] - The top three stocks with net outflows are Tencent Holdings (00700) with -1.20 billion, Anta Sports (02020) with -697 million, and Rongchang Biopharmaceutical (09995) with -584 million [1][2] - In terms of net inflow ratio, Datang Renewable (01798) leads with 74.45%, followed by Shenzhen Expressway (00548) with 50.53%, and Bosideng (03998) with 50.23% [1][3] - The top three stocks with the highest net outflow ratios are Chongqing Rural Commercial Bank (03618) at -58.46%, Kington Services (09666) at -54.34%, and Poly Property Group (00119) at -51.88% [1][3] Net Inflow Rankings - The top ten stocks by net inflow include: - China Life (02628): 1.58 billion, 34.91% increase, closing price 23.620 (+3.60%) [2] - Southern Hang Seng Technology (03033): 768 million, 14.65% increase, closing price 5.475 (-0.90%) [2] - Alibaba-W (09988): 452 million, 4.38% increase, closing price 121.800 (-1.54%) [2] - Other notable stocks include Li Auto-W (02015) with 349 million and AIA Group (01299) with 317 million [2] Net Outflow Rankings - The top ten stocks by net outflow include: - Tencent Holdings (00700): -1.20 billion, -5.56% decrease, closing price 590.000 (+0.68%) [2] - Anta Sports (02020): -697 million, -40.49% decrease, closing price 92.450 (+2.72%) [2] - Rongchang Biopharmaceutical (09995): -584 million, -33.65% decrease, closing price 77.450 (+13.65%) [2] - Other notable stocks include Meituan-W (03690) with -387 million and China Construction Bank (00939) with -366 million [2] Net Inflow Ratio Rankings - The top stocks by net inflow ratio include: - Datang Renewable (01798): 74.45%, net inflow of 14.5175 million, closing price 2.360 (+0.85%) [3] - Shenzhen Expressway (00548): 50.53%, net inflow of 8.719 million, closing price 7.020 (0.00%) [3] - Bosideng (03998): 50.23%, net inflow of 6.728 million, closing price 4.630 (+0.65%) [3]

Core Viewpoint - Ark Health (06086) experienced a nearly 10% intraday increase, closing up 8.64% at HKD 3.9, with a trading volume of HKD 66.72 million, following the announcement of a strategic cooperation memorandum with global biopharmaceutical leader Novo Nordisk [1] Group 1 - Ark Health, as a leading AI and internet healthcare company, aims to establish a comprehensive health management service loop covering medication guidance, reminders, effect tracking, and health education [1] - The collaboration is focused on transforming diabetes and obesity management from a "disease-centered" approach to a "health-centered" model, providing patients with higher quality and more convenient one-stop services [1] - The strategic partnership is expected to create a new ecological value chain in the field of glycemic control and weight loss [1]

Core Viewpoint - Ark Health (06086) experienced a nearly 10% intraday increase, closing up 8.64% at HKD 3.9, with a trading volume of HKD 66.72 million, following the announcement of a strategic cooperation memorandum with Novo Nordisk, a global leader in biopharmaceuticals [1] Group 1 - Ark Health, as a leading AI and internet healthcare company, aims to establish a comprehensive health management service loop covering medication guidance, reminders, effect tracking, and health education [1] - The collaboration with Novo Nordisk is expected to create a new ecological value chain in the fields of diabetes and obesity, shifting the focus from "disease-centered" to "health-centered" approaches [1] - The initiative is designed to provide patients with higher quality and more convenient one-stop services [1]

Core Viewpoint - Ark Health (06086) has seen a significant stock increase of 8.64% to HKD 3.9, with a trading volume of HKD 66.72 million, following the announcement of a strategic cooperation memorandum with Novo Nordisk, a global leader in biopharmaceuticals [1] Group 1 - Ark Health is positioned as a leading AI and internet healthcare company, leveraging its smart healthcare ecosystem and strong technological foundation [1] - The collaboration aims to create a comprehensive health management service loop that includes medication guidance, reminders, effect tracking, and health education [1] - The initiative focuses on transforming diabetes and obesity management from a "disease-centered" approach to a "health-centered" model, providing patients with higher quality and more convenient one-stop services [1]

Group 1 - The company, Ark Health (06086.HK), will hold a board meeting on August 27, 2025, to review and approve its interim results for the six months ending June 30, 2025 [1] - The meeting will also consider the proposal for the distribution of an interim dividend, if any [1]

承董事會命 方舟云康控股有限公司 主席 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不會就本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Fangzhou Inc. 方舟云康控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：6086） 董事會會議日期 方舟雲康控股有限公司（「本公司」）董事會（「董事會」）謹此宣佈，本公司將 於2025年8月27日（星期三）舉行董事會會議，藉以（其中包括）考慮及批准本 公司及其附屬公司截至2025年6月30日止六個月之中期業績及其發佈，並考 慮派發中期股息（如有），及處理其他事項。 謝方敏先生 香港，2025年8月15日 於本公告日期，董事會由執行董事謝方敏先生、 ZHOU Feng 先生及鄒宇鳴先 生；非執行董事 David McKee HAND 先生；及獨立非執行董事王海忠博士、 康韋女士及朱小路先生組成。 ...

为了响应国家关于发展人工智能的工作部署，充分应用人工智能技术，提升健康医疗服务水平，加快卫 生健康智能化数字化升级，各地积极推进建设人工智能应用场景，其中，地方发布"人工智能+医疗卫 生"应用场景案例，充分应用人工智能技术，提升互联网医疗服务效率和质量，加快互联网医疗智能化 数字化升级，助力行业高质量发展。 在第三届中国国际供应链促进博览会上，方舟健客（06086.HK）依托其AI应用服务场景、便捷药事服 务等资源，与全球领先的生物制药公司诺和诺德正式签署战略合作备忘录，携手诺和诺德围绕糖尿病和 肥胖症等严重慢性疾病的管理展开项目合作。 战略合作备忘录签署仪式上，谢方敏表示，希望能携手全球生物医药龙头企业诺和诺德，通过探索AI 技术的应用，突破传统健康管理模式中的痛点，为全球控糖管理、体重管理领域提供创新的数智化标杆 方案。 方舟健客创始人、董事长兼首席执行官谢方敏带领企业以科技创新为驱动力，加强与合作伙伴的交流合 作，共同探索行业创新发展新生态。 紧跟行业发展趋势，抓住技术创新机遇 对于人工智能等新技术带来的新发展机遇，方舟健客创始人、董事长兼首席执行官谢方敏指出，自成立 以来，方舟健客深深明白"科技赋能" ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 方舟云康控股有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06086 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,500,000,000 | USD | | 0.00002 | USD | | 50,000 | | 增加 / 減少 (-) | | | 0 | | | | USD | | 0 | | 本月底結存 | | | 2,500,000,000 | USD | | 0.00002 | USD | | 50,000 | 本月底法定/註冊股本總額： USD 50,000 FF301 截至 ...

Group 1 - The artificial intelligence industry is undergoing a new round of transformation, with breakthroughs in large model capabilities and a rapid decrease in inference costs driving the swift development of large model applications [1] - Experts at the 2025 Global Digital Economy Conference highlighted that the significant decline in costs over the past year has provided essential foundational conditions for accelerating the implementation of AI applications [1] Group 2 - The internet healthcare sector is experiencing an upgrade opportunity driven by the AI digital wave, focusing on enhancing user experience through intelligent solutions that address user pain points and meet diverse needs [2] - Ark Health has developed the "H2H Smart Healthcare New Ecosystem Service Platform" to improve user service experience, leveraging deep technological expertise and innovative research [2] - The platform has seen a substantial increase in registered users, growing from 42.7 million at the end of 2023 to 49.2 million, with a monthly active user count rising by 20% to 10.1 million [2] Group 3 - AI technology is significantly reshaping industry forms and social life, with China accounting for 42% of the world's "lighthouse factories" and AI medical applications improving early lung cancer screening accuracy to 97% [3] - Ark Health's H2H service platform integrates AI into various application scenarios within internet healthcare, exploring broader possibilities for future industry development [3] - The company has established strategic collaborations with Tencent Cloud and Tencent Health to innovate AI applications in pharmaceutical distribution and health management, enhancing the quality and efficiency of internet healthcare [3]